ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AV. Aviva Plc

468.70
-2.00 (-0.42%)
Last Updated: 08:57:17
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Aviva Plc LSE:AV. London Ordinary Share GB00BPQY8M80 ORD 32 17/19P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00 -0.42% 468.70 468.60 468.80 469.80 465.70 465.70 628,616 08:57:17
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Insurance Carriers, Nec 41.43B 1.09B 0.3962 11.88 12.89B
Aviva Plc is listed in the Insurance Carriers sector of the London Stock Exchange with ticker AV.. The last closing price for Aviva was 470.70p. Over the last year, Aviva shares have traded in a share price range of 366.00p to 499.40p.

Aviva currently has 2,738,270,828 shares in issue. The market capitalisation of Aviva is £12.89 billion. Aviva has a price to earnings ratio (PE ratio) of 11.88.

Aviva Share Discussion Threads

Showing 22576 to 22600 of 44850 messages
Chat Pages: Latest  906  905  904  903  902  901  900  899  898  897  896  895  Older
DateSubjectAuthorDiscuss
09/3/2017
08:24
Just in case anyone can't be bothered wading through 2 million pages to the end of part 4 of the announcement for the unimportant dividend details:-

2017 financial calendar

Ordinary 2016 final dividend ex-dividend date*

6 April 2017

2016 final dividend record date (Ordinary and ADR)

7 April 2017

Last day for Dividend Reinvestment Plan and currency election for 2016 final dividend

25 April 2017

Annual General Meeting

11am on 10 May 2017

2016 final dividend payment date*

17 May 2017

cwa1
09/3/2017
08:13
Pah! Share buybacks are a waste of shareholders' money. Give me the cash.
Great numbers and a great outlook though. Another good year ahead. £6 by Christmas - no ramp intended.

lord gnome
09/3/2017
08:06
Wynmack you beat me to it 😀
dr biotech
09/3/2017
08:05
Wilson on CNBC says rather will move towards a payout ratio of 50%. Capital return next year more likely to be a share buyback.
dr biotech
09/3/2017
08:05
Mark Wilson on cnbc...cap return."maybe in the form of a buyback"
wynmck
09/3/2017
07:54
CWA1

Thanks for that info, plenty to wade through on these results.

Did you clock the date and amount of the normal divi as well.

Thanks again.

billy5
09/3/2017
07:51
At the VERY top!!

We are now actively planning a capital return to our shareholders and debt reduction in 2017 and will invest further to grow our businesses.

cwa1
09/3/2017
07:47
Oggyrocks,

Special divi?

Where is that mentioned in results?

utyinv
09/3/2017
07:26
Look excellent. Special divided on way too.
oggyrocks
09/3/2017
07:07
Profit
· Operating profit2,3 up 12% to £3,010 million (2015: £2,688 million4)
· Operating EPS2,3 up 3% to 51.1p (2015: 49.7p4)
· Operating profit and operating EPS exclude the impact of the change in the Ogden discount rate in UK general insurance, which has been classified as an exceptional item
· IFRS profit after tax down 22% to £859 million (2015: £1,097 million4) including the £380 million after-tax charge due to the reduction in the Ogden discount rate

1B1BCapital
· Solvency II capital surplus5 £11.3 billion (2015: £9.7 billion)
· Solvency II coverage ratio5,6 of 189% (2015: 180%)
· Solvency II operating capital generation £3.5 billion
· Net asset value up 6% to 414p per share (2015: 390p4)
· Holding company liquidity7 £1.8 billion (2015: £1.3 billion)

2B2B15BCash
· 2016 total dividend up 12% to 23.3p (2015: 20.8p)
· Dividend pay-out ratio 46% (2015: 42%4), progress towards 50% target
· Cash remittances up 20% to £1,805 million (2015: £1,507 million)

3B3B16BGrowth
· General insurance net written premiums3 up 15% to £8,211 million (2015: £7,171 million)
· Life insurance value of new business up 13% to £1,352 million (2015: £1,192 million)
· Fund management operating profit up 30% to £138 million (2015: £106 million)
· AIMS AUM trebled to £9 billion (2015: £3 billion)
· Total group assets under management up to £450 billion

4B4B17BCombined ratio
· General insurance combined operating ratio 95.2% (2015: 94.6%) excluding the Ogden discount rate impact. Including the Ogden impact, the combined operating ratio was 101.1%.

skinny
08/3/2017
08:15
Why would anyone red tick a bullish post??? ;))
alphorn
07/3/2017
21:10
Results under Wilson have exceeded forecasts so far and the so has gone up on results day. I'm not so sure this time, but AV doesn't keep me awake guessing like it used to either
dr biotech
07/3/2017
17:26
Closed out some naked calls today as expecting results to be okish. Small loss, but am now net long.
alphorn
07/3/2017
12:45
Of course!
bracke
07/3/2017
12:26
A position I suspect you are well versed in.
uppompeii
07/3/2017
11:18
Hmmmmm....... a considered trade based on a branch of fundamentals sometimes referred to as the 'revenge' analysis. This has the added advantage that if it is successful the satisfaction index is greatly increased beyond mere cash, not to mention that the investor considers it a move to the moral high ground.
bracke
07/3/2017
11:08
Added some in anticipation of karma for Moss screwing me over round about this time 5 or 6 years ago...
uppompeii
01/3/2017
15:47
One hidden bonus, I bought some av.b shares in December and theyve quietly added around 5%.
uppompeii
01/3/2017
12:00
Well there's half your fence!
skinny
01/3/2017
11:59
Good day uppompeii

Mr Trumps speech not assisted the share price much. It's still 'piddling' around with 500. Doesn't inspire apart from the odd 10p.

bracke
28/2/2017
18:55
Some longer term sipp but a quick 10p to replace some fencing taken down last week...sounds fair I believe
uppompeii
28/2/2017
17:20
Good day uppompeii

No ire and not necessarily a bad move.

It depends on your target and what you are looking to achieve.

As may be expected the share price is meeting resistance at 500. It's broken up a couple of times but unable to stay there. It has been forming a base at 493.

Following the intraday high of 512 it dropped to 493. It did try again but could not get to 512 and again dropped to 493.

Depends which gives first 500 or 493. Perhaps Mr Trump's speech will resolve the situation.

bracke
28/2/2017
15:16
May take a nibble here again before results, hoping not to raise bracke's ire but I'm sure he will say it's a bad move....
uppompeii
22/2/2017
13:56
Apparently the Spanish assets may soon be sold, according to Bloomberg.
dr biotech
19/2/2017
16:37
Well aside the 93% that are held by banks and nominee companies!
uppompeii
Chat Pages: Latest  906  905  904  903  902  901  900  899  898  897  896  895  Older

Your Recent History

Delayed Upgrade Clock